Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials.

Saved in:
Bibliographic Details
Title: Does HLA-B27 Status Influence Ixekizumab Efficacy in Axial Spondyloarthritis? Results From the COAST-V, COAST-W, and COAST-X Trials.
Authors: Reveille, John D.1 (AUTHOR) john.d.reveille@uth.tmc.edu, Rudwaleit, Martin2 (AUTHOR), Rahman, Proton3 (AUTHOR), Maldonado-Cocco, Jose A.4 (AUTHOR), Magrey, Marina5 (AUTHOR), Bolce, Rebecca6 (AUTHOR), Ng, Khai Jing6 (AUTHOR), Gibble, Theresa Hunter6 (AUTHOR), Lisse, Jeffrey6 (AUTHOR), Park, So Young6 (AUTHOR), Kronbergs, Andris6 (AUTHOR), Navarro-Compán, Victoria7 (AUTHOR)
Source: Rheumatology & Therapy. Feb2026, Vol. 13 Issue 1, p279-291. 13p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21986576
DOI:10.1007/s40744-025-00810-5